Public, Private Initiatives Advance Mexico’s MedTech Sector

Mexico is reinforcing its position in the medical device sector and expanding healthcare infrastructure as the country participates in MD&M West 2026 and implements large-scale acquisitions of high-technology medical equipment. The efforts aim to attract investment, strengthen domestic manufacturing, and modernize diagnostic and treatment capabilities across public institutions.

“Mexico offers certitude, specialized talent, and access to North American markets for companies seeking to diversify production and invest in high-value medical operations,” said Olga Martínez, Advisor on Medical Devices, Ministry of Economy, summarizing the government’s strategy at the trade event.

The Ministry of Economy, together with the governments of Baja California and Chihuahua, presented a package of investment incentives targeting companies in sensors, microcameras, robotic surgery, sterilization, assembly, advanced electronics, silicone components, regulatory engineering, and automated manufacturing. The package includes workforce training, dual-education schemes, fiscal incentives, regulatory guidance, and support for integration into local supply chains. These measures align with Mexico’s broader objective of enhancing export capacity, employment quality, and technological content in the medical device sector.

In parallel, the country is modernizing public healthcare infrastructure through significant equipment acquisitions. The Mexican Social Security Institute (IMSS) is investing MX$1.7 billion (US$87.4 million) to deploy 123 imaging systems—including mammography, CT, MRI, and pediatric biplane angiography units—across 26 states. The procurement, completed through competitive dialogue and direct manufacturer purchases, reduces the initial budget by nearly 45% and covers installation, site adaptations, and staff training. Zoé Robledo, Director General, highlighted the modernization will improve diagnostics in oncology, cardiology, neurology, pulmonology, and pediatric care, while reducing patient wait times.

The IMSS effort forms part of a larger consolidated plan for 2026, in which Mexico’s public health sector will acquire 816 high-tech devices, including CT scanners, MRI systems, mammography units, linear accelerators, PET-CT scanners, gamma cameras, angiography systems, and brachytherapy equipment. The MX$11.3 billion (US$619 million) initiative spans IMSS, ISSSTE, IMSS Bienestar, PEMEX health services, and the National Institutes of Health, with deliveries and installations scheduled throughout the year. Authorities emphasize that this procurement model, based on competitive dialogue and reverse auctions, prioritizes efficiency, direct manufacturer engagement, and defined delivery and warranty conditions.

Experts note that regulatory stability and technical continuity are key for leveraging these investments. Erick Ponce Flores, President, Mexican Chamber of the Medical Cannabis Industry, stressed that sudden leadership changes at regulatory agencies such as COFEPRIS can undermine institutional trust, affecting investment and innovation. “Progress in healthcare depends on trust between regulators, industry, and patients,” he said, noting that consistency in technical leadership is crucial for sustained growth in medical technology and therapeutics.

Healthcare innovation is also being shaped by digital tools. A 2026 study in The Lancet Digital Health highlighted a “digital recovery lag” in patients recovering from COVID-19, influenza, and group A streptococcus, showing that individuals often return to normal activity before physiological recovery is complete. Continuous monitoring via smartwatches and digital platforms revealed persistent cardiovascular strain even after symptoms resolved, suggesting that integration of wearable data could inform clinical guidance, workplace policies, and insurance models. Industry executives indicate that digital health tools, combined with AI analytics, can improve predictive care, personalize interventions, and enhance efficiency in public health delivery.

By combining targeted investment incentives, large-scale equipment procurement, and digital health adoption, Mexico aims to strengthen both domestic production and patient care outcomes while positioning itself as a regional leader in medical devices and healthcare innovation.